Coagulopathy in Childhood Acute Lymphoblastic Leukaemia

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2028

Conditions
Acute Lymphoblastic LeukemiaThrombosisBleedingHemostatic Disorder
Interventions
DIAGNOSTIC_TEST

Coagulopathy parameters

"Standard coagulation tests: APT (Activated Partial Thromboplastin Time), PT/INR (Prothrombin Time Test), Protein-C, Protein-S, Fibrinogen, Antithrombin, D-dimers.~Global haemostasis assays: CAT (Calibrated Automated Thrombogram), OHP (Overall Haemostatic Potential), Fibrin clot turbidity assay, microparticle detection by flow cytometry, scanning electron microscopy.~Protein expression profile (mass spectroscopy)~Ultrasound of catheterised neck veins to detect clots"

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

Karolinska University Hospital

OTHER

NCT06242353 - Coagulopathy in Childhood Acute Lymphoblastic Leukaemia | Biotech Hunter | Biotech Hunter